{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:02:08Z","timestamp":1785240128307,"version":"3.55.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.1093\/ehjopen\/oeag118","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:50:06Z","timestamp":1783770606000},"source":"Crossref","is-referenced-by-count":0,"title":["Angiotensin-converting enzyme inhibitors show an edge over angiotensin II receptor blockers in cardiovascular outcomes"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-1911","authenticated-orcid":false,"given":"Carl J","family":"Lavie","sequence":"first","affiliation":[{"name":"John Ochsner Heart and Vascular Institute, Ochsner Clinical School\u2013University of Queensland School of Medicine , New Orleans, LA 70112 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":false,"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[{"name":"Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL) , Rzgowska 281\/289, 93-338 Lodz ,","place":["Poland"]},{"name":"Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"2026072807174229900_oeag118-B1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ehjcvp\/pvae084","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension: what is new in pharmacotherapy","volume":"11","author":"McCarthy","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026072807174229900_oeag118-B2","first-page":"e114","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"152","author":"Writing Committee Members*","year":"2025","journal-title":"Circulation"},{"key":"2026072807174229900_oeag118-B3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/CIRCULATIONAHA.121.057835","article-title":"Why are we still prescribing angiotensin-converting enzyme inhibitors?","volume":"145","author":"Messerli","year":"2022","journal-title":"Circulation"},{"key":"2026072807174229900_oeag118-B4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mayocp.2015.10.019","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials","volume":"91","author":"Bangalore","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2026072807174229900_oeag118-B5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N Engl J Med"},{"key":"2026072807174229900_oeag118-B6","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/eurheartj\/ehs075","article-title":"Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin\u2013angiotensin\u2013aldosterone system inhibitors involving 158 998 patients","volume":"33","author":"van Vark","year":"2012","journal-title":"Eur Heart J"},{"key":"2026072807174229900_oeag118-B7","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.mayocp.2022.06.036","article-title":"Effect of the renin-angiotensin system inhibitors on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials","volume":"97","author":"Awad","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"2026072807174229900_oeag118-B8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.mayocp.2022.11.018","article-title":"In reply: ACEI and ARB\u2014each unique RAAS inhibitors: the importance of impact on inflammation","volume":"98","author":"Awad","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"2026072807174229900_oeag118-B9","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeag119","article-title":"Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular and non-cardiovascular outcomes in patients at high\/very-high cardiovascular risk without heart failure: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials","author":"Masi","year":"2026","journal-title":"Eur Heart J Open"},{"key":"2026072807174229900_oeag118-B10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.2019.17521","article-title":"Changes in utilization of generic angiotensin receptor blockers following product recalls in the United States","volume":"323","author":"Desai","year":"2020","journal-title":"JAMA"},{"key":"2026072807174229900_oeag118-B11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","article-title":"Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study","volume":"78","author":"Chen","year":"2021","journal-title":"Hypertension"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/6\/4\/oeag118\/70253966\/oeag118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/6\/4\/oeag118\/70253966\/oeag118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:17:50Z","timestamp":1785237470000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oeag118\/8743986"}},"subtitle":[],"editor":[{"given":"Magnus","family":"B\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oeag118","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7,1]]},"article-number":"oeag118"}}